Heterologous Intrauterine Insemination

The goal of light hormonal therapy is to stimulate the growth of 1-2 follicles. Follicular maturation and the continued growth of the uterine lining is monitored per ultrasound.

Based on the size of the follicles, the thickness of the uterus lining, and through ovulation tests, the point of ovulation can be predicted. In most cases, ovulation is medically induced once the follicles have achieved a certain size – providing the best time for the insemination.

The donor semen selected for heterologous insemination is prepared in the laboratory and then inserted into the female’s uterus through the cervix using a thin, flexible plastic tube called a catheter. In most cases, this procedure does not cause any complications, pain, or discomfort.

If treatment with heterologous insemination is decided, both partners must be in agreement on this matter and they must both agree to treatment. This agreement must be confirmed in writing, either through a notarial deed or a court record.

The probability of becoming pregnant with this method is approximately 15-20% per cycle.